Trials / Completed
CompletedNCT04581135
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
Prospective Observational Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 620 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19.
Detailed description
COVID-19 is a coronavirus induced viral pneumonia leading to Acute Respiratory Distress Syndrome. Previous coronavirus infections (SARS and MERS) led to pulmonary fibrosis in up to 30%. Prospective evaluation of lung abnormalities and pulmonary fibrosis after COVID-19 infection is crucial as novel treatments against lung fibrosis of different etiologies are available. No data on pulmonary longterm effects in COVID-19 survivors are currently available. The nation-wide Swiss COVID-19 lung group establishes a meticulously characterized prospective cohort study on pulmonary long-term sequela of patients living in Switzerland.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | COVID-19 | Research project in which biological material is sampled and health-related personal data are collected and used for further research. Coded data are used. |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2022-01-30
- Completion
- 2022-01-30
- First posted
- 2020-10-09
- Last updated
- 2023-03-14
Locations
9 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04581135. Inclusion in this directory is not an endorsement.